High-Level <i>MYCN-</i>Amplified <i>RB1-</i>Proficient Retinoblastoma Tumors Retain Distinct Molecular Signatures.

Roohollahi, Khashayar; de Jong, Yvonne; van Mil, Saskia E; Fabius, Armida W M; Moll, Annette C; Dorsman, Josephine C

High-Level MYCN-Amplified RB1-Proficient Retinoblastoma Tumors Retain Distinct Molecular Signatures.

Roohollahi, Khashayar; de Jong, Yvonne; van Mil, Saskia E; Fabius, Armida W M; Moll, Annette C; Dorsman, Josephine C.

Afiliación

Roohollahi K; Department of Human Genetics, Amsterdam UMC, Amsterdam, The Netherlands.
de Jong Y; Department of Human Genetics, Amsterdam UMC, Amsterdam, The Netherlands.
van Mil SE; Department of Ophthalmology, Amsterdam UMC, Amsterdam, The Netherlands.
Fabius AWM; Department of Human Genetics, Amsterdam UMC, Amsterdam, The Netherlands.
Moll AC; Department of Ophthalmology, Amsterdam UMC, Amsterdam, The Netherlands.
Dorsman JC; Department of Ophthalmology, Amsterdam UMC, Amsterdam, The Netherlands.

Ophthalmol Sci ; 2(3): 100188, 2022 Sep.

Article en En | MEDLINE | ID: mdl-36245757

Palabras clave

FC, fold change; GEO, Gene Expression Omnibus; LOH, loss of heterozygosity; MYCN; Methylation analysis; RB1; RMA, robust multiarray average; Retinoblastoma; Transcriptomics

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ophthalmol Sci Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google